BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 747513)

  • 1. [Chemotherapy in Hodgkin's disease (author's transl)].
    Schmidt CG
    Arch Geschwulstforsch; 1978; 48(5):407-15. PubMed ID: 747513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K; Utsumi M; Shimoyama M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
    Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
    Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
    Bonadonna G; Santoro A; Bonfante V; Valagussa P
    Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies.
    Bloomfield CD; Pajak TF; Glicksman AS; Gottlieb AJ; Coleman M; Nissen NI; Rafla S; Stutzman L; Vinciguerra V; Glidewell OJ; Holland JF
    Cancer Treat Rep; 1982 Apr; 66(4):835-46. PubMed ID: 6176320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic failures in early stages of Hodgkin's disease : causes and prevention (author's transl)].
    Dubois JB; Broquerie JL; Pourquier H; Pujol H; Izarn P; Navarro M; Donadio D
    Bull Cancer; 1981; 68(1):19-24. PubMed ID: 7225605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
    Baillet F; Brun B; Maylin C; Mazeron JJ; Pierquin B; Dreyfus B
    J Radiol Electrol Med Nucl; 1977 May; 58(5):343-6. PubMed ID: 886528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease.
    Young CW; Straus DJ; Myers J; Passe S; Nisce LZ; Lee BJ; Koziner B; Arlin Z; Kempin S; Gee T; Clarkson BD
    Cancer Treat Rep; 1982 Apr; 66(4):907-14. PubMed ID: 7042090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternating chemotherapy and radiation therapy in the treatment of advanced Hodgkin's disease.
    Grigoraki V; Merle-Beral H; Touboul E; Gabarre J; Lesty C; Binet JL
    Nouv Rev Fr Hematol (1978); 1988; 30(4):219-24. PubMed ID: 3194187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy of lymphogranulomatosis in adulthood].
    Dühmke E
    Praxis (Bern 1994); 1996 Mar; 85(12):371-7. PubMed ID: 8643900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
    Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
    Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
    Bonadonna G
    Cancer Res; 1982 Nov; 42(11):4309-20. PubMed ID: 6181867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
    Cunningham J; Mauch P; Rosenthal DS; Canellos GP
    Cancer Treat Rep; 1982 Apr; 66(4):1015-22. PubMed ID: 7074629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-gonadic complications of chemoradiotherapy in Hodgkin's disease. A study of eighty-three patients (author's transl)].
    Bolla M; Sotto JJ; Barjhoux R; Kolodie H; Vincent F; Michallet M; Sarrazin R; Vrousos C; Hollard D
    Sem Hop; 1982 Jan; 58(4):204-8. PubMed ID: 6280286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
    J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.